Purchase Order 75N93019P01145

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) on September 16, 2019, with a ceiling value of $19,158.00. No set-aside was used. Performance is at Bethesda, Maryland. The order is firm fixed price. Ultimate completion is September 16, 2020.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Standard Biotools Inc. (doing business as Fluidigm) for $19,158.00 on September 17, 2018, with ultimate completion on September 16, 2019. The order covers a BioMark HD Standard Service Plan on a firm fixed price basis. Performance occurs at Standard Biotools' facility in South San Francisco, California.</p>

This is a $11,224.90 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Standard Biotools Inc. (doing business as Fluidigm), a for-profit manufacturer of scientific instruments and reagents. The contract is for the delivery of various antibodies with a period of performance ending on May 31, 2018. Standard Biotools is an established federal contractor...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $51,245.60 firm-fixed-price purchase order to Standard Biotools Inc., doing business as Fluidigm, for the supply of antibodies and parts for the Helios instrumentation. Fluidigm is a for-profit manufacturer that supports the scientific community in solving challenges in health and disease research. The company has provided goods and services to...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. for $19,987.50 on August 24, 2020, for antibodies. Performance is located in San Diego, California with completion scheduled for September 23, 2020. This firm fixed-price acquisition carries no small business set-aside.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. valued at $6,892.26 on August 9, 2018, for antibodies. The order was issued as a firm fixed-price acquisition with no set-aside. Place of performance is San Diego, California. The ultimate completion date is August 8, 2019. The purchase order was issued to de-obligate expiring FY'18 funds.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. for $10,292.25 on August 29, 2019, for antibodies with a completion date of September 30, 2019. Work is performed in San Diego, California. The order is a firm fixed-price acquisition with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Biolegend, Inc. for $102,869 on September 16, 2019. The order covers antibodies and related biomedical reagents. Place of performance is San Diego, California. The ultimate completion date is October 16, 2019. The requirement originated from a pre-solicitation posted September 11, 2019, with award on the same date as the stated due date.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on July 5, 2019, for fluorescently conjugated monoclonal antibodies and flow cytometry custom conjugates and consumables for vaccine research and pre-clinical monitoring, with a ceiling value of $6,425.00. Place of performance is San Jose, CA. Ultimate completion date is August 9, 2019. The order is priced on a firm fixed price basis and was issued without a set-aside.

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson and Company on August 30, 2018, with a ceiling value of $8,642.30 for fluorescently conjugated monoclonal antibodies for research and pre-clinical monitoring of vaccine applications and flow cytometry consumables.</p> <p>Place of performance is San Jose, CA. The order is firm fixed price with an ultimate completion date of September 11, 2018. No set-aside was used.</p>